Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of MC5-A ("Scrambler") Therapy in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Phase II Pilot Trial

NCT00952848 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT00952848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00952848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of MC5-A ("Scrambler") Therapy in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Phase II Pilot Trial
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Completed
Start date
June 12, 2009
Completion date
June 30, 2010
Enrollment
18 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapeutic agent toxicity, neurotoxicity, pain, peripheral neuropathy, unspecified adult solid tumor, protocol specific